Circular RNAs as molecular bridges: dual regulation of ferroptosis and immunity in cancer

Songbai Xu1, Peiyi Liang2, Tie Lin3

  • 1Department of Neurosurgery, First Hospital of Jilin University, Changchun, China.

Insights

Circular RNAs (circRNAs) regulate ferroptosis and anti-tumor immunity in cancer. This review explores circRNA dual regulation of these pathways for novel cancer diagnostics and therapies.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Circular RNAs (circRNAs) are stable RNA molecules with regulatory roles.
  • Ferroptosis is a distinct cell death pathway crucial in cancer.
  • Tumor immune microenvironment (TIME) remodeling impacts cancer progression and therapy.

Purpose of the Study:

  • To review circRNA-mediated crosstalk between ferroptosis and anti-tumor immunity in cancer.
  • To elucidate molecular mechanisms of this dual regulation.
  • To explore circRNAs as biomarkers and therapeutic targets.

Main Methods:

  • Literature review of circRNA functions in cancer.
  • Analysis of molecular mechanisms including miRNA sponging, protein interactions, and peptide encoding.
  • Focus on circRNA's role in ferroptosis-immunity crosstalk.

Main Results:

  • CircRNAs act as "molecular bridges" regulating ferroptosis and anti-tumor immunity simultaneously.
  • This "dual regulation" targets key nodes in both pathways.
  • Three major regulatory modalities of circRNAs were identified.

Conclusions:

  • CircRNAs offer novel therapeutic strategies by dual targeting of ferroptosis and immune pathways.
  • CircRNAs show potential as non-invasive biomarkers for cancer.
  • Understanding circRNA-mediated crosstalk advances precision cancer therapy.

Related Concept Videos

Transcriptional Regulation: Riboswitches01:23

Transcriptional Regulation: Riboswitches

Riboswitches are RNA elements that regulate gene expression by altering their secondary structures in response to specific effector molecules. These elements, located in the leader regions of certain mRNAs, act as transcriptional regulators by toggling between alternative conformations to control downstream gene expression. Riboswitch-mediated regulation is a precise mechanism for modulating biosynthetic pathways, as exemplified by the riboflavin biosynthesis pathway in Bacillus...
Experimental RNAi02:15

Experimental RNAi

RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...